Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference
- Corporate and Finance
Dec 6, 2016
Novavax to Participate in the Citi 2016 Global Healthcare Conference
- Corporate and Finance
Nov 30, 2016
Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference
- Corporate and Finance
Nov 22, 2016
Novavax Reports Third Quarter 2016 Financial Results
- Corporate and Finance
Nov 9, 2016
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016
- Corporate and Finance
Nov 2, 2016
UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016
- Corporate and Finance
Nov 2, 2016
Novavax Reschedules 4th Annual Investor and Analyst Meeting
- Corporate and Finance
Oct 7, 2016
Novavax to Host 4th Annual Investor and Analyst Meeting
- Corporate and Finance
Oct 4, 2016
Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults
- RSV
Sep 15, 2016
Novavax to Host 4th Annual Investor and Analyst Meeting
- Corporate and Finance
Sep 7, 2016
Novavax Reports Second Quarter 2016 Financial Results
- Corporate and Finance
Aug 9, 2016
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016
- Corporate and Finance
Aug 2, 2016
Novavax Recognized by Washington Post as Top Workplace
- Corporate and Finance
Jun 17, 2016
Novavax Announces New Seasonal Combination Respiratory Vaccine Program
- RSV
Jun 2, 2016
U.S. FDA Grants Fast Track Designation to Novavax’ RSV F Vaccine for Older Adults
- RSV
May 26, 2016
Novavax Receives the Tech Council of Maryland’s Chairman’s Award
- Corporate and Finance
May 12, 2016
Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day
- Corporate and Finance
May 11, 2016
Novavax Reports First Quarter 2016 Financial Results
- Corporate and Finance
May 4, 2016
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 4, 2016
- Corporate and Finance
Apr 27, 2016
Novavax to Participate in the FBR New Prescriptions Conference
- Corporate and Finance
Apr 13, 2016
Novavax to Present at the 15th Annual Needham Healthcare Conference
- Corporate and Finance
Apr 6, 2016
Novavax Announces Management Promotion
- Corporate and Finance
Apr 4, 2016
Novavax Appoints Bob Darius Senior Vice President, Quality Operations
- Corporate and Finance
Mar 17, 2016
Novavax Reports Fourth Quarter and Year-End 2015 Financial Results
- Corporate and Finance
Feb 29, 2016
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016
- Corporate and Finance
Feb 22, 2016
Novavax Announces Exercise of Over-Allotment Option to Purchase Additional Shares
- Corporate and Finance
Feb 5, 2016
Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023
- Corporate and Finance
Jan 29, 2016
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023
- Corporate and Finance
Jan 25, 2016
Novavax Prices $300 Million of Convertible Senior Notes Due 2023
- Corporate and Finance
Jan 25, 2016
Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs
- Corporate and Finance
Jan 8, 2016
Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference
- Corporate and Finance
Jan 6, 2016
Novavax Appoints Mark Twyman Vice President Marketing
- Corporate and Finance
Dec 21, 2015
Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
- RSV
Dec 14, 2015
Novavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference
- Corporate and Finance
Dec 8, 2015
Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization
- RSV
Dec 3, 2015
Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference
- Corporate and Finance
Nov 24, 2015
Novavax to Make Multiple Presentations at RSV Vaccines for the World
- RSV
Nov 16, 2015
Novavax to Present at the Stifel 2015 Healthcare Conference
- Corporate and Finance
Nov 10, 2015
Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
- RSV
Nov 9, 2015
Novavax Reports Third Quarter 2015 Financial Results
- Corporate and Finance
Nov 9, 2015
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015
- Corporate and Finance
Nov 2, 2015
Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults
- RSV
Oct 22, 2015
Novavax Announces Management Promotion
- Corporate and Finance
Oct 1, 2015
Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization
- RSV
Sep 29, 2015
Novavax Announces Positive Top-Line Data from Phase 2 Clinical Trial of RSV F Vaccine to Protect Infants via Maternal Immunization
- RSV
Sep 29, 2015
Novavax to Host 3rd Annual Analyst and Investor Meeting
- Corporate and Finance
Sep 29, 2015
Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics
- RSV
Sep 29, 2015
Novavax to Present at the Ladenburg Thalmann 2015 Healthcare Conference
- Corporate and Finance
Sep 21, 2015
Novavax RSV F Vaccine is Highly Immunogenic With Robust Transplacental Antibody Transfer in Preclinical Maternal Immunization Model
- RSV
Sep 15, 2015
Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease
- RSV
Sep 10, 2015

Show per page